Pharma Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Addiction Medicine
Study supports a flexible approach to methadone dosing
February 27th, 2006
New study findings support a flexible approach to methadone dosing for treatment of heroin addicts. Methadone has been used for more than 30 years as a treatment for heroin addicts. Doctors have struggled to find the best doses to help patients overcome their heroin cravings without getting them used to higher levels of methadone (itself an dependence-forming substance) than necessary. A new study by Jodie Trafton, VA Palo Alto Health Care System, and colleagues provides strong support for the notion that there is no one dose that fits all. It appears in the journal PLoS Medicine (Determining effective methadone doses for individual...
Source: Pharma Business Week (2006-02-27)
|
